RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY

Aim. Evaluation of long-term results of drug therapy and intramyocardial administration of a mononuclear fraction of bone marrow cells in CHD patients with chronic cardiac insufficiency. Materials and methods. 109 patients were randomized into two groups by using an envelope method. Intramyocardial...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Cherniavsky, Ye. N. Kliever, Ye. A. Pokushalov, A. B. Romanov, I. N. Terekhov, Ye. E. Kliever
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2013-10-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849338592916144128
author A. M. Cherniavsky
Ye. N. Kliever
Ye. A. Pokushalov
A. B. Romanov
I. N. Terekhov
Ye. E. Kliever
author_facet A. M. Cherniavsky
Ye. N. Kliever
Ye. A. Pokushalov
A. B. Romanov
I. N. Terekhov
Ye. E. Kliever
author_sort A. M. Cherniavsky
collection DOAJ
description Aim. Evaluation of long-term results of drug therapy and intramyocardial administration of a mononuclear fraction of bone marrow cells in CHD patients with chronic cardiac insufficiency. Materials and methods. 109 patients were randomized into two groups by using an envelope method. Intramyocardial administration of a mononuclear fraction of autologous bone marrow cells and cardiac insufficiency therapy were performed for the 1st group (n = 55), while the 2nd group (n = 54) received drug therapy only. All patients underwent clinical examination at admission and at 6 and 12 months after the onset of the study. Results. In the 1st group the angina functional class was reliably lowered (from 3.3 ± 0.2 at the onset of the study down to 2.5 ± 0.1 after 12 months). The distance covered during a 6-minute walk test increased from the initial 185 ± 39 meters up to 359 ± 69 me- ters by the end of the 12th month. The angina class decreased from 3.1 ± 0.4 at the onset of the study down to 1.6 ± 0.4 by the end of the 12th month. Minnesota Life Quality Index reduced from 65.3 ± 21 points down to 22.4 ± 6 points in the first group, while in the control one it decreased down to 59.9 ± 16 points. On the contrary, cardiac insufficiency in patients of the second group tended to continually progress: from NYHA FC 3.5 ± 0.1 at the beginning of the study up to 3.9 ± 0.1 in the course of 12-month observation. The angina class remained the same (3.5 ± 0.5 at the beginning and 3.5 ± 0.4 after 12 months respectively). Conclusion. Intramyocardial implantation of a mononuclear fraction of autologous bone marrow cells is a safe method that contributes to the improvement of the left ventricular function, clinical data and prognosis.
format Article
id doaj-art-2baafadeebe84811828f5b7154cabaa0
institution Kabale University
issn 1995-1191
language Russian
publishDate 2013-10-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Вестник трансплантологии и искусственных органов
spelling doaj-art-2baafadeebe84811828f5b7154cabaa02025-08-20T03:44:21ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovВестник трансплантологии и искусственных органов1995-11912013-10-01153839110.15825/1995-1191-2013-3-83-91377RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCYA. M. Cherniavsky0Ye. N. Kliever1Ye. A. Pokushalov2A. B. Romanov3I. N. Terekhov4Ye. E. Kliever5Center for Aorta & Coronary Arteries Cardiac Surgery (Head – doct. of med. sci., professor A.M. Cherniavsky), Ye.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk, Russian FederationCenter for Aorta & Coronary Arteries Cardiac Surgery (Head – doct. of med. sci., professor A.M. Cherniavsky), Ye.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk, Russian FederationCenter for Surgical Arrhythmology (Head – doct. of med. sci. Ye.A. Pokushalov), Ye.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk, Russian FederationCenter for Surgical Arrhythmology (Head – doct. of med. sci. Ye.A. Pokushalov), Ye.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk, Russian FederationDepartment of Radiology & Functional Diagnostics X-Ray CAT Division (Head – cand. of med. sci. V.P. Kurbatov) Ye.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk, Russian FederationElectron Microscopy&Pathomorphology Laboratory (Head – doct. of med. sci. A.M. Volkov), Ye.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk, Russian FederationAim. Evaluation of long-term results of drug therapy and intramyocardial administration of a mononuclear fraction of bone marrow cells in CHD patients with chronic cardiac insufficiency. Materials and methods. 109 patients were randomized into two groups by using an envelope method. Intramyocardial administration of a mononuclear fraction of autologous bone marrow cells and cardiac insufficiency therapy were performed for the 1st group (n = 55), while the 2nd group (n = 54) received drug therapy only. All patients underwent clinical examination at admission and at 6 and 12 months after the onset of the study. Results. In the 1st group the angina functional class was reliably lowered (from 3.3 ± 0.2 at the onset of the study down to 2.5 ± 0.1 after 12 months). The distance covered during a 6-minute walk test increased from the initial 185 ± 39 meters up to 359 ± 69 me- ters by the end of the 12th month. The angina class decreased from 3.1 ± 0.4 at the onset of the study down to 1.6 ± 0.4 by the end of the 12th month. Minnesota Life Quality Index reduced from 65.3 ± 21 points down to 22.4 ± 6 points in the first group, while in the control one it decreased down to 59.9 ± 16 points. On the contrary, cardiac insufficiency in patients of the second group tended to continually progress: from NYHA FC 3.5 ± 0.1 at the beginning of the study up to 3.9 ± 0.1 in the course of 12-month observation. The angina class remained the same (3.5 ± 0.5 at the beginning and 3.5 ± 0.4 after 12 months respectively). Conclusion. Intramyocardial implantation of a mononuclear fraction of autologous bone marrow cells is a safe method that contributes to the improvement of the left ventricular function, clinical data and prognosis.https://journal.transpl.ru/vtio/article/view/434mononuclear fraction of autologous bone marrow cellscardiac insufficiencycoronary heart disease.
spellingShingle A. M. Cherniavsky
Ye. N. Kliever
Ye. A. Pokushalov
A. B. Romanov
I. N. Terekhov
Ye. E. Kliever
RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY
Вестник трансплантологии и искусственных органов
mononuclear fraction of autologous bone marrow cells
cardiac insufficiency
coronary heart disease.
title RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY
title_full RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY
title_fullStr RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY
title_full_unstemmed RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY
title_short RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY
title_sort results of intramyocardial administration of a mononuclear fraction of autologous bone marrow cells in chd patients with concomitant cardiainsufficiency
topic mononuclear fraction of autologous bone marrow cells
cardiac insufficiency
coronary heart disease.
url https://journal.transpl.ru/vtio/article/view/434
work_keys_str_mv AT amcherniavsky resultsofintramyocardialadministrationofamononuclearfractionofautologousbonemarrowcellsinchdpatientswithconcomitantcardiainsufficiency
AT yenkliever resultsofintramyocardialadministrationofamononuclearfractionofautologousbonemarrowcellsinchdpatientswithconcomitantcardiainsufficiency
AT yeapokushalov resultsofintramyocardialadministrationofamononuclearfractionofautologousbonemarrowcellsinchdpatientswithconcomitantcardiainsufficiency
AT abromanov resultsofintramyocardialadministrationofamononuclearfractionofautologousbonemarrowcellsinchdpatientswithconcomitantcardiainsufficiency
AT interekhov resultsofintramyocardialadministrationofamononuclearfractionofautologousbonemarrowcellsinchdpatientswithconcomitantcardiainsufficiency
AT yeekliever resultsofintramyocardialadministrationofamononuclearfractionofautologousbonemarrowcellsinchdpatientswithconcomitantcardiainsufficiency